Science
New report describes positive results of generic drug in treating COVID – PRNewswire
/PRNewswire/ — The Covid Early Treatment Fund (CETF) www.treatearly.org announced today that the medical journal Open Forum Infectious Diseases published a…
BERKELEY, Calif., Feb. 1, 2021 /PRNewswire/ — The Covid Early Treatment Fund (CETF) www.treatearly.org announced today that the medical journal Open Forum Infectious Diseases published a report that outlines the success in using a generic drug fluvoxamine to prevent complications of COVID-19.
“This real-world evidence study provides additional independent confirmation that fluvoxamine is highly effective in preventing hospitalization and death from COVID,” said Steve Kirsch, a Silicon Valley…
Continue Reading
